Animate Biosciences Launches Breakthrough Generative AI Platform Revolutionizing Inflammatory and Fibrotic Disease Treatment Through Peptide Therapeutics
Animate Biosciences today unveiled its breakthrough platform for developing peptide therapeutics to treat inflammatory and fibrotic disease, one of the most pressing challenges in medicine. Affecting nearly every organ and implicated in close to half of global deaths, inflammatory and fibrotic disease has long lacked safe and effective treatments. Now, using its proprietary AnimateIQ™ platform, Animate harnesses multi-omics data from regenerative species then applies generative AI to translate those insights into precisely designed, well-tolerated peptides. With lead programs in pulmonary and dermatological inflammatory and fibrotic diseases, as well as collaborations in cardiac fibrosis, Animate is building a scalable pipeline aimed at treating both rare and high-prevalence conditions.
